TRRI — Alzex Neuropharma Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.03m
- $0.09m
Annual cashflow statement for Alzex Neuropharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | — | — |
| Status: | Final | Final |
| Net Income/Starting Line | -0.075 | -0.038 |
| Depreciation | ||
| Non-Cash Items | 0 | -0.028 |
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.01 | 0.067 |
| Change in Accounts Receivable | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | 0 | 0.001 |
| Capital Expenditures | 0 | 0 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | 0 | 0 |
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 0 | 0 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0 | 0.001 |